Register for SOSV’s HAX demo days in SF (4/29) and Newark (5/6)

Making Every Breath Count

GET CONNECTED
stradoslabs.com

Team

Nick Delmonico

Co-Founder

Richard Powers

Founder

Strados Labs

Company details

Strados’ system detects pulmonary abnormalities earlier and more often through a small skin worn stethoscope that measures breathing patterns and lung sounds (like wheezing or coughing).

Human HealthUnited StatesSeries A(+)Consumer DevicesHard TechHAX 2018

Company News

Gozen Raises $3.3M In Seed Funding – FinSMEs

October 26, 2023
FinSMEs

Strados Labs Remote Wearable in BI IPF Trial – Applied Clinical Trials

February 4, 2023
Applied Clinical Trials Online

Respiratory device company Strados Labs raised $4.5M, with 2022 hiring plans – Technical.ly Philly

January 6, 2022
Technical.ly Philly

Strados Labs Raises $4.5M in Pre-Series A Funding Round – FinSMEs

January 6, 2022
FinSMEs

Philadelphia medical technology firm looks to raise more capital, expand global reach

April 7, 2021
Philadelphia Business Journal

Get In Touch with Strados Labs

Please tell us a little bit about yourself and why you'd like to get connected. Strados Labs + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More